Aliases & Classifications for Teratoma

Aliases & Descriptions for Teratoma:

Name: Teratoma 12 52 42 14 69
Teratomas 12 29

Classifications:



External Ids:

Disease Ontology 12 DOID:3307
MeSH 42 D013724
NCIt 47 C3403
UMLS 69 C0039538

Summaries for Teratoma

Disease Ontology : 12 A germ cell and embryonal cancer that is an encapsulated tumor with tissue or organ components resembling normal derivatives of all three germ layers.

MalaCards based summary : Teratoma, also known as teratomas, is related to ovarian germ cell teratoma and struma ovarii. An important gene associated with Teratoma is AFP (Alpha Fetoprotein), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Etoposide and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include ovary, testis and thyroid, and related phenotypes are Increased shRNA abundance (Z-score > 2) and cellular

Wikipedia : 71 A teratoma is a tumor with tissue or organ components resembling normal derivatives of more than one... more...

Related Diseases for Teratoma

Diseases in the Teratoma family:

Malignant Teratoma Adult Teratoma
Intermediate Malignant Teratoma

Diseases related to Teratoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 529)
id Related Disease Score Top Affiliating Genes
1 ovarian germ cell teratoma 33.0 AFP KIT SYP
2 struma ovarii 32.0 AFP KRT20 KRT7 SYP
3 cystadenoma 29.8 ENO2 SYP TP53
4 pneumonia 29.6 AFP ENO2 GFAP KIT
5 testicular cancer 29.5 CDX2 KIT KRT20 KRT7 NKX2-1 TP53
6 apocrine adenocarcinoma 29.4 CDX2 KRT20 KRT7
7 medullomyoblastoma 29.4 AFP KRT7 SYP
8 ovarian embryonal carcinoma 29.4 KIT NKX2-1 TP53
9 duodenal obstruction 29.4 KRT7 NKX2-1 SYP
10 gastric duplication cysts 29.4 POU5F1 SOX2 SYP
11 glomus tumor 29.3 ENO2 KIT SYP
12 hemolytic anemia 29.3 ACTC1 ENO2 NKX2-1 SYP
13 sebaceous adenoma 29.2 ACTC1 KIT SYP
14 sacrococcygeal teratoma 12.3
15 growing teratoma syndrome 12.1
16 teratoma with malignant transformation 12.1
17 cystic teratoma 12.0
18 malignant teratoma 12.0
19 immature teratoma of ovary 11.9
20 mature teratoma 11.9
21 gastric teratoma 11.9
22 central nervous system teratoma 11.9
23 adult teratoma 11.8
24 ovarian cystic teratoma 11.8
25 pineal region teratoma 11.8
26 mature teratoma of the ovary 11.8
27 malignant gastric teratoma 11.8
28 nasopharyngeal teratoma 11.8
29 mature gastric teratoma 11.8
30 mediastinum teratoma 11.8
31 fallopian tube teratoma 11.8
32 adult cystic teratoma 11.8
33 extragonadal teratoma 11.7
34 intermediate malignant teratoma 11.7
35 spinal cord intramedullary teratoma 11.7
36 adult central nervous system teratoma 11.7
37 central nervous system mature teratoma 11.7
38 central nervous system immature teratoma 11.7
39 ovarian solid teratoma 11.7
40 pineal region mature teratoma 11.7
41 pineal region immature teratoma 11.7
42 benign pericardial teratoma 11.7
43 testicular germ cell tumor 11.7
44 adult central nervous system mature teratoma 11.6
45 adult central nervous system immature teratoma 11.6
46 childhood mature teratoma of the ovary 11.6
47 childhood teratoma of the ovary 11.6
48 ovarian fetiform teratoma 11.6
49 childhood central nervous system mature teratoma 11.6
50 childhood central nervous system immature teratoma 11.6

Graphical network of the top 20 diseases related to Teratoma:



Diseases related to Teratoma

Symptoms & Phenotypes for Teratoma

GenomeRNAi Phenotypes related to Teratoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-114 9.47 AFP
2 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.47 AFP
3 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.47 POU5F1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.47 POU5F1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-135 9.47 KRT7
6 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.47 POU5F1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-192 9.47 KRT7 POU5F1 AFP
8 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.47 AFP
9 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.47 POU5F1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.47 AFP
11 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.47 KRT7 POU5F1

MGI Mouse Phenotypes related to Teratoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.18 ACTC1 CDX2 ENO2 GFAP GRN KIT
2 behavior/neurological MP:0005386 10.17 GFAP GRN KIT MNX1 NKX2-1 POU5F1
3 homeostasis/metabolism MP:0005376 10.03 ACTC1 AFP CDX2 CGA GFAP GRN
4 digestive/alimentary MP:0005381 9.97 CDX2 GFAP KIT MNX1 NKX2-1 POU5F1
5 endocrine/exocrine gland MP:0005379 9.97 AFP CDX2 CGA KIT MNX1 NKX2-1
6 nervous system MP:0003631 9.9 CGA ENO2 GFAP GRN KIT MNX1
7 normal MP:0002873 9.65 MNX1 NKX2-1 POU5F1 SOX2 SYP TP53
8 reproductive system MP:0005389 9.28 AFP CDX2 CGA GRN TP53 KIT

Drugs & Therapeutics for Teratoma

Drugs for Teratoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 174)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 4,Phase 2,Phase 3,Phase 1 33419-42-0 36462
2
Cisplatin Approved Phase 4,Phase 2,Phase 3,Phase 1 15663-27-1 84093 441203 2767
3
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
4
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
5
Mechlorethamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
6 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
7 Topoisomerase Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
8 Etoposide phosphate Phase 4,Phase 2,Phase 3,Phase 1
9 Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1
10 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1
11 Antineoplastic Agents, Phytogenic Phase 4,Phase 2,Phase 3,Phase 1
12
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
13
Vinblastine Approved Phase 3 865-21-4 13342 241903
14
Paclitaxel Approved, Vet_approved Phase 2, Phase 3, Phase 1 33069-62-4 36314
15
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
16
Bleomycin Approved Phase 2, Phase 3 11056-06-7 5360373
17
Oxaliplatin Approved, Investigational Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 6857599, 9887054 43805
18
Mesna Approved Phase 3,Phase 1,Phase 2 3375-50-6 598
19
Lenograstim Approved Phase 2, Phase 3, Phase 1 135968-09-1
20
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
21
Captopril Approved Phase 3 62571-86-2 44093
22
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
23
Ribavirin Approved Phase 3 36791-04-5 37542
24
Fluconazole Approved Phase 3 86386-73-4 3365
25
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
26
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
27 Sodium thiosulfate Approved Phase 3,Phase 1
28
Palivizumab Approved, Investigational Phase 3 188039-54-5
29
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
30
Succinylcholine Approved Phase 3 306-40-1 5314
31
Diphenhydramine Approved Phase 3 58-73-1, 147-24-0 3100
32
Promethazine Approved Phase 3 60-87-7 4927
33
Ondansetron Approved Phase 3 99614-02-5 4595
34
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
35 Dexamethasone acetate Phase 3,Phase 2,Phase 1 1177-87-3
36 Adjuvants, Immunologic Phase 3,Phase 1,Phase 2
37 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
38 Albumin-Bound Paclitaxel Phase 2, Phase 3, Phase 1
39 Hormone Antagonists Phase 3,Phase 2,Phase 1
40 Dexamethasone 21-phosphate Phase 3,Phase 2,Phase 1
41 Hormones Phase 3,Phase 2,Phase 1
42 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
43 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
44 Anti-Bacterial Agents Phase 2, Phase 3, Phase 1
45 Anti-Infective Agents Phase 3,Phase 1,Phase 2
46 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
47 Antiemetics Phase 3,Phase 2,Phase 1
48 Liver Extracts Phase 3,Phase 2,Phase 1
49 Antimetabolites Phase 3,Phase 1,Phase 2
50 Antibiotics, Antitubercular Phase 2, Phase 3, Phase 1

Interventional clinical trials:

(show top 50) (show all 98)
id Name Status NCT ID Phase
1 Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors Recruiting NCT01424839 Phase 4
2 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3
3 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3
4 Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy Unknown status NCT02097446 Phase 3
5 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3
6 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3
7 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
8 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
9 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
10 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
11 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
12 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3
13 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed NCT00716976 Phase 3
14 Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst. Completed NCT02009228 Phase 3
15 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3
16 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3
17 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Active, not recruiting NCT00053352 Phase 3
18 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Active, not recruiting NCT01346267 Phase 3
19 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Active, not recruiting NCT00085202 Phase 3
20 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3
21 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2
22 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2
23 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2
24 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Completed NCT00301782 Phase 2
25 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2
26 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2
27 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2
28 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2
29 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Completed NCT00091182 Phase 2
30 Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors Completed NCT00002489 Phase 2
31 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
32 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2
33 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
34 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
35 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
36 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2
37 Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer Completed NCT00004077 Phase 2
38 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Completed NCT00047320 Phase 2
39 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors Completed NCT00002472 Phase 2
40 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors Completed NCT00003811 Phase 2
41 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Completed NCT00024258 Phase 2
42 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Completed NCT00003173 Phase 2
43 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2
44 Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Completed NCT00047177 Phase 2
45 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2
46 Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy Recruiting NCT02317393 Phase 2
47 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Recruiting NCT01037790 Phase 2
48 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
49 Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Recruiting NCT02114229 Phase 2
50 A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression Active, not recruiting NCT02300987 Phase 2

Search NIH Clinical Center for Teratoma

Cochrane evidence based reviews: teratoma

Genetic Tests for Teratoma

Genetic tests related to Teratoma:

id Genetic test Affiliating Genes
1 Teratoma 29

Anatomical Context for Teratoma

MalaCards organs/tissues related to Teratoma:

39
Ovary, Testis, Thyroid, Brain, Bone, Eye, Pineal

Publications for Teratoma

Articles related to Teratoma:

(show top 50) (show all 2418)
id Title Authors Year
1
Endoscopic Resection of Skull Base Teratoma in Klippel-Feil Syndrome through Use of Combined Ultrasonic and Bipolar Diathermy Platforms. ( 28133560 )
2017
2
Teratoma-associated NMDAr encephalitis: management considerations. ( 28012265 )
2017
3
Benign cystic mediastinal teratoma presenting as a massive pleural effusion in a 17-year-old boy. ( 28073871 )
2017
4
Metastatic Mucinous Adenocarcinoma and Carcinoid Tumor Arising From a Mature Cystic Teratoma of a Horseshoe Kidney. ( 28083486 )
2017
5
Lower abdominal gossypiboma mimics ovarian teratoma: a case report and review of the literature. ( 28061867 )
2017
6
Cushing's syndrome in infancy due to ectopic ACTH secretion by a sacro-coccygeal teratoma. ( 28328532 )
2017
7
An ovarian mature cystic teratoma evolving in squamous cell carcinoma: A case report and review of the literature. ( 28050596 )
2017
8
Well-formed cerebellum and brainstem-like structures in a mature ovarian teratoma: Neuropathological observations. ( 28042664 )
2017
9
Analysis of Recurrent Sacrococcygeal Teratoma in Children: Clinical Features, Relapse Risks, and Anorectal Functional Sequelae. ( 28042962 )
2017
10
Fetus in Fetu in Lieu of a Sacrococcygeal Teratoma: A Case Illuminating the Utility of Serial Prenatal Sonographic Examinations in Diagnosis. ( 28026891 )
2017
11
Utilization of a submental island flap and 3D printed model for skull base reconstruction: Infantile giant cranio-cervicofacial teratoma. ( 28012516 )
2017
12
Compact MRI for the detection of teratoma development following intrathecal human embryonic stem cell injection in NOD-SCID mice. ( 28069364 )
2017
13
Adrenal Teratoma: a Case Series and Review of the Literature. ( 28091891 )
2017
14
Intradural sacral mature teratoma associated with a low-lying conus. ( 28084287 )
2017
15
Evaluation of chemotherapeutic sequelae and quality of life in survivors of malignant sacrococcygeal teratoma. ( 26667016 )
2016
16
Upper Lumbar Mature Cystic Teratoma: A Case Report. ( 27641261 )
2016
17
Malignant melanoma arising in a mature teratoma: A case report with review of the recent literature. ( 27331138 )
2016
18
Mature cystic teratoma coexisting with clear-cell carcinoma in the ovary. ( 27987343 )
2016
19
How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma? ( 27258729 )
2016
20
Mature Cystic Teratoma of the Ovary With Three Kinds of Entire Gastrointestinal Wall and Complete Bronchial Structure in a Pregnant Woman. ( 27098586 )
2016
21
Immature Orbital Teratoma With Intracranial Extension. ( 27526235 )
2016
22
Immature Gastric Teratoma in a Newborn: A Case Report. ( 27123405 )
2016
23
Gluteal teratoma: A rare site of extragonadal teratoma. ( 27695210 )
2016
24
Anaesthestic management of sacrococcygeal teratoma in infants. ( 27212735 )
2016
25
Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report. ( 27911225 )
2016
26
Radiotherapy for persistent malignant transformation from mature cystic teratoma of the ovary. ( 26889642 )
2016
27
Management of Familial Ovarian Teratoma: The Need for Guidance. ( 28018806 )
2016
28
Autoamputation of an ovarian mature cystic teratoma: a case report and a review of the literature. ( 27535361 )
2016
29
Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report. ( 27434195 )
2016
30
Gliomatosis Peritonei Arising in Setting of Immature Teratoma of Ovary: A Case Report and Review of Literature. ( 27298531 )
2016
31
Giant intra-abdominal mature cystic teratoma (dermoid cyst) in an adult male, with male genitourinary tissue including prostatic and penile elements. ( 27038684 )
2016
32
Antenatal Diagnosis of a Large Immature Abdominal Wall Teratoma by 2D-3D Ultrasound Using HDlive and Magnetic Resonance Imaging. ( 27560103 )
2016
33
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. ( 26485622 )
2016
34
A case of mature teratoma with a falsely high serum estradiol value measured with an immunoassay. ( 26974135 )
2016
35
Mature cystic teratoma of mediastinum with pleural effusion: An uncommon entity. ( 27098949 )
2016
36
Squamous Cell Carcinoma Arising in Background of Mature Cystic Teratoma. ( 27981940 )
2016
37
Rapid recovery from catastrophic paraneoplastic anti-NMDAR encephalitis secondary to an ovarian teratoma following ovarian cystectomy. ( 27511754 )
2016
38
Acardiac twin pregnancies part II: Fetal risk of chorangioma and sacrococcygeal teratoma predicted by pump/acardiac umbilical vein diameters. ( 27273226 )
2016
39
Situs inversus totalis with a mature teratoma of the posterior mediastinum: A case report. ( 26893706 )
2016
40
MRI findings in intraspinal mature teratoma. ( 27180081 )
2016
41
Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders. ( 27604214 )
2016
42
Acute reversible seronegative cerebellar ataxia in a young woman with ovarian teratoma. ( 27653894 )
2016
43
Recurrent 'growing teratoma syndrome' in an adolescent girl with a history of ovarian immature teratoma: A case report. ( 27147511 )
2016
44
A rare case of microinvasive squamous cell carcinoma arising in mature cystic teratoma of the ovary. ( 27352578 )
2016
45
Port-site metastasis after laparoscopic surgery for mature cystic teratoma. ( 27172754 )
2016
46
Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation. ( 26980033 )
2016
47
Testicular Seminoma Occurring After Kidney Transplantation in a Patient Previously Treated for Teratoma: De Novo Malignancy or Recurrence in a Different Histologic Form? ( 27932163 )
2016
48
EP21.23: Ex utero intrapartum treatment (EXIT) procedure for cervical teratoma. ( 27645029 )
2016
49
Traumatic Rupture of A Posterior Mediastinal Teratoma following Motor-Vehicle Accident. ( 27660731 )
2016
50
VACTERL Association with Sacrococcygeal Teratoma. ( 27567656 )
2016

Variations for Teratoma

Expression for Teratoma

Search GEO for disease gene expression data for Teratoma.

Pathways for Teratoma

GO Terms for Teratoma

Biological processes related to Teratoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.55 ACTC1 KIT NKX2-1 POU5F1 TP53
2 regulation of transcription from RNA polymerase II promoter GO:0006357 9.43 CDX2 CGA CGB3 KIT MNX1 NKX2-1
3 endodermal cell fate specification GO:0001714 9.26 POU5F1 SOX2
4 somatic stem cell population maintenance GO:0035019 8.92 CDX2 KIT POU5F1 SOX2

Molecular functions related to Teratoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 miRNA binding GO:0035198 8.62 POU5F1 SOX2

Sources for Teratoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....